1 |
Mehmetbeyoglu E, Kianmehr L, Borlu M, Yilmaz Z, Basar Kılıc S, Rajabi-maham H, Taheri S, Rassoulzadegan M. Decrease in RNase HII and Accumulation of lncRNAs/DNA Hybrids: A Causal Implication in Psoriasis? Biomolecules 2022;12:368. [DOI: 10.3390/biom12030368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
2 |
Lin I, Melsheimer R, Bhak RH, Lefebvre P, DerSarkissian M, Emond B, Lax A, Nguyen C, Wu M, Young-Xu Y. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin 2022;:1-33. [PMID: 35125053 DOI: 10.1080/03007995.2022.2037846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Hillhouse E, Mathurin K, Bibeau J, Parison D, Rahal Y, Lachaine J, Beauchemin C. The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review. Adv Ther 2022;39:455-87. [PMID: 34780028 DOI: 10.1007/s12325-021-01951-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
4 |
Morf H, Witte T. [Use of biosimilars in the treatment of rheumatoid arthritis : An overview]. Z Rheumatol 2021. [PMID: 34825948 DOI: 10.1007/s00393-021-01129-6] [Reference Citation Analysis]
|
5 |
Mehmetbeyoglu E, Kianmehr L, Borlu M, Yilmaz Z, Kılıc SB, Rajabi-maham H, Taheri S, Rassoulzadegan M. The accumulation of lncRNAs in hybrid with DNA in patients with psoriasis reveals a decrease in the levels of RNase HII transcripts in the skin.. [DOI: 10.1101/2021.10.12.464167] [Reference Citation Analysis]
|